MGEN - miRagen Therapeutics Inc. (MGEN) CEO William Marshall on Q4 2018 Results - Earnings Call Transcript
miRagen Therapeutics, Inc. (MGEN)
Q4 2018 Earnings Conference Call
March 13, 2019 04:30 PM ET
Company Participants
Daniel Ferry - LifeSci Advisors, LLC
William Marshall - Co-Founder, President and Chief Executive Officer
Jason Leverone - Chief Financial Officer
Paul Rubin - Executive Vice President of Research and Development
Adam Levy - Chief Business Officer
Conference Call Participants
Jonathan Miller - Evercore ISI
Suji Jeong - Jefferies LLC
Vasiliana Moussatos - Wedbush Securities Inc.
Madhu Kumar - Robert W. Baird & Co.
George Zavoico - B. Riley FBR, Inc.
Ari Wald - Oppenheimer & Co. Inc.